Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
DOP033: Immunogenicity profile and predictors of TLs and ADA development of biosimilar infliximab during the first 6 months of the therapy: results from a prospective nationwide cohort
Year: 2016
Source: ECCO'16 DOP
Authors: Lovasz B.
anti-TNF, biosimilars, infliximab, real world data, anti-TNF drug levels, anti drug antibodies
Files: 1
DOP033: Severely active Ulcerative Colitis is associated with high baseline infliximab clearance, reduced serum half-life and worse endoscopic outcomes
Year: 2017
Source: ECCO'17 Barcelona
Authors: Vande Casteele N.
Theraputic drug monitoring, Anti-TNF agents, Infliximab, Pharmacokinetics, Treat to target
Files: 1
DOP033: Trends in epidemiology of Inflammatory Bowel Disease among Jewish Israeli adolescents: A population based study
Year: 2018
Source: ECCO'18 Vienna
Authors: Ghersin Itai
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP034: Assessment of direct healthcare cost drivers of Crohn's Disease in a Dutch population-based cohort study shows a major shift
Year: 2018
Source: ECCO'18 Vienna
Authors: Lalisang Robbert
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP034: Comparative effectiveness of infliximab and adalimumab in Crohn’s disease: results from a real-life population-based cohort
Year: 2016
Source: ECCO'16 DOP
Authors: Jeuring S.
Anti-TNF agents, real world data
Files: 1
DOP034: Serum adalimumab concentration 3 months after surgery is correlated with endoscopic recurrence in Crohn’s Disease patients treated with adalimumab for prevention of postoperative recurrence
Year: 2017
Source: ECCO'17 Barcelona
Authors: Boivineau L.
Crohn's diease, Adalimumab,Pharmacokinetics, Post-operative IBD
Files: 1
DOP035: High gammaglobulin and low albumin serum levels independently predict secondary loss of response to anti-TNFα therapy in IBD
Year: 2017
Source: ECCO'17 Barcelona
Authors: Schoenefuss F.
Therapeutic drug monitoring, Anti-TNF agents, Adalimumab, Infliximab
Files: 1
DOP035: Longterm outcome of inflammatory bowel disease patients with deep remission after discontinuation of TNFα –blocking agents
Year: 2016
Source: ECCO'16 DOP
Authors: Molander P.
Anti-TNF agents, real world data
Files: 1
DOP036: Infliximab discontinuation is associated with a higher risk for relapse in patients with ulcerative colitis in remission: a multinational collaborative retrospective study
Year: 2016
Source: ECCO'16 DOP
Authors: Fiorino G.
Ulcerative Colitis, infliximab, real world dara
Files: 1
DOP036: The therapeutic efficacy of anti-TNF requires Fc-gamma receptors and can be improved by antibody hypo-fucosylation
Year: 2017
Source: ECCO'17 Barcelona
Authors: Bloemendaal F.
Anti-TNF agents, Immunology, Macrophage
Files: 1
DOP036: Ustekinumab for Crohn's Disease: A nationwide real-life observational cohort study (ICC Case Series)
Year: 2018
Source: ECCO'18 Vienna
Authors: Biemans Vince
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP037: A model for prediction of early surgery and complications in paediatric Crohn’s Disease; Results of the prospective GROWTH CD study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Levine A.
paediatric, post operative complications, digestive tract damage
Files: 1
DOP037: Excess steroid use in IBD: too much, how much and why? Results from a UK nationwide audit
Year: 2016
Source: ECCO'16 DOP
Authors: Selinger C.
Crohn's Disease, Ulcerative Colitis, corticosteroids, real world data
Files: 1
DOP037: Postoperative anti-TNF therapy is associated with a significant reduction of both endoscopic and clinical recurrence following surgery for ileocolonic Crohn's Disease: Results of a prospective nationwide cohort conducted by the GETAID chirurgie group
Year: 2018
Source: ECCO'18 Vienna
Authors: Maggiori Léon
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP038: Analytical and clinical validation of a rapid point-of-care assay for infliximab quantification in patients with ulcerative colitis
Year: 2016
Source: ECCO'16 DOP
Authors: Van Stappen T.
infliximab, anti TNF drug levels, therapeutic drug monitoring
Files: 1
DOP038: Postoperative outcome in 2890 patients following right hemicolectomy and ileo-cecal resection in colonic cancer and Crohn’s Disease: Results from ESCP-SECCO snapshot prospective audit 2015
Year: 2018
Source: ECCO'18 Vienna
Authors: Dich Grandt Sanne
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP039: Exploring stoma rates in Crohn’s Disease in the biologic era: A population-based time trend analysis
Year: 2018
Source: ECCO'18 Vienna
Authors: Ma Christopher
Created: Tuesday, 8 May 2018, 11:36 AM
Files: 1
DOP039: Point-of-care monitoring of infliximab trough levels in capillary fingerstick blood of patients with inflammatory bowel disease (IBD)
Year: 2016
Source: ECCO'16 DOP
Authors: Maljaars J.
infliximab, anti TNF drug levels, therapeutic drug monitoring
Files: 1
DOP039: Postoperative infectious complications in Crohn’s Disease: results from PRACTICROHN study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Gutiérrez A.
Crohn's disease, Ileo caecal resection, Post operative complications
Files: 1
DOP03: The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes’ polymorphisms
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Agnieszka Surowiecka-Pastewka
Created: Tuesday, 28 May 2019, 3:32 PM
Genetic factors
Files: 1